Quantity size:
0.2ml
Concentration:
1mg/ml 胰岛素样生长因子I受体抗体 Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
This receptor binds insulin-like growth factor with a high affinity. It has tyrosine kinase activity. The insulin-like growth factor I receptor plays a critical role in transformation 胰岛素样生长因子I受体抗体events. Cleavage of the precursor generates alpha and beta subunits. It is highly overexpressed in most malignant tissues where it functions as an anti-apoptotic agent by enhancing cell survival. [provided by RefSeq, Jul 2008].
胰岛素样生长因子I受体抗体Also known as:
CD221; CD221 antigen; IGF1 Receptor; IGF 1 receptor; IGF 1R; IGF I receptor; IGF1R; IGFIR; IGFIRC; Insulin like growth factor 1 receptor; Insulin like growth factor 1 receptor precursor; JTK13; MGC142170; MGC142172; IGF1R_HUMAN; Insulin-like growth factor 1 receptor beta chain; IGF 1 receptor; IGF-1R; IGF I receptor; IGF-I receptor.
Specificity:
●
Rabbit Polyclonal IgG,胰岛素样生长因子I受体抗体 affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Horse, Rabbit, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human IGF-1R a.
●
胰岛素样生长因子I受体抗体Predicted Molecular Weight: 78/150kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 Flow-Cyt=1: 50-300 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl102Cp01基质金属蛋白酶7(MMP7)多克隆抗体Polyclonal Antibody to Matrix Metalloproteinase 7 (MMP7)
kl102Eq01基质金属蛋白酶7(MMP7)多克隆抗体Polyclonal Antibody to Matrix Metalloproteinase 7 (MMP7)
kl102Hu01基质金属蛋白酶7(MMP7)多克隆抗体Polyclonal Antibody to Matrix Metalloproteinase 7 (MMP7)
kl102Mu01基质金属蛋白酶7(MMP7)多克隆抗体Polyclonal Antibody to Matrix Metalloproteinase 7 (MMP7)
kl102Ra01基质金属蛋白酶7(MMP7)多克隆抗体Polyclonal Antibody to Matrix Metalloproteinase 7 (MMP7)
kl103Gu01基质金属蛋白酶8(MMP8)多克隆抗体Polyclonal Antibody to Matrix Metalloproteinase 8 (MMP8)
kl103Hu01基质金属蛋白酶8(MMP8)多克隆抗体Polyclonal Antibody to Matrix Metalloproteinase 8 (MMP8)
kl103Mu01基质金属蛋白酶8(MMP8)多克隆抗体Polyclonal Antibody to Matrix Metalloproteinase 8 (MMP8)
kl103Ra01基质金属蛋白酶8(MMP8)多克隆抗体Polyclonal Antibody to Matrix Metalloproteinase 8 (MMP8)
kl104Bo01胆囊收缩素A受体(CCKAR)多克隆抗体Polyclonal Antibody to Cholecystokinin A Receptor (CCKAR)
kl104Ca01胆囊收缩素A受体(CCKAR)多克隆抗体Polyclonal Antibody to Cholecystokinin A Receptor (CCKAR)
kl104Ga01胆囊收缩素A受体(CCKAR)多克隆抗体Polyclonal Antibody to Cholecystokinin A Receptor (CCKAR)
kl104Gu01胆囊收缩素A受体(CCKAR)多克隆抗体Polyclonal Antibody to Cholecystokinin A Receptor (CCKAR)
kl104Hu01胆囊收缩素A受体(CCKAR)多克隆抗体Polyclonal Antibody to Cholecystokinin A Receptor (CCKAR)
kl104Mu01胆囊收缩素A受体(CCKAR)多克隆抗体Polyclonal Antibody to Cholecystokinin A Receptor (CCKAR)
kl104Ra01胆囊收缩素A受体(CCKAR)多克隆抗体Polyclonal Antibody to Cholecystokinin A Receptor (CCKAR)
kl104Rb51胆囊收缩素A受体(CCKAR)多克隆抗体Polyclonal Antibody to Cholecystokinin A Receptor (CCKAR)
kl105Bo01神经生长因子(NGF)多克隆抗体Polyclonal Antibody to Nerve Growth Factor (NGF)
kl105Ga01神经生长因子(NGF)多克隆抗体Polyclonal Antibody to Nerve Growth Factor (NGF)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话